Skip Navigation
Text Size
Home > ARRA Stories > Dr. Mary Wagner: Congenital Heart Defects
Dr. Mary Wagner: Congenital Heart Defects

Emory University recently received over 150 awards totaling more than $53 million in American Recovery and Reinvestment Act (ARRA) stimulus-funding from several different institutes within the National Institutes of Health (NIH). These awards will support meritorious research projects, administrative supplements for ongoing projects, faculty recruitment, training programs, student research experiences and the creation of new jobs. Detailed below is one of the research projects supported by ARRA funds.

Photo of Dr. Mary Wagner

Dr. Mary Wagner

Congenital heart defects are the leading cause of birth-defect-related deaths in children. Advances in surgery have made it possible to correct many congenital heart defects, but often children will still require additional treatment such as medication to stabilize their heart function.

Children's hearts respond differently to medications and surgery than adults? hearts, and more information is needed to guide pediatric heart specialists. Dr. Mary Wagner's stimulus grant will allow her to look at physiological properties of human heart tissue from pediatric patients, such as the ability to contract and to respond to electrical signals.

Pediatric Heart Development video

Working with CHOA to Study Congenital Heart Defects video

These video clips are courtesy of Emory University. Reposted with permission.

Related Links

Search Stories:

Project Details

Research/Disease Category

  • Cardiovascular
  • Clinical Research
  • Heart Disease
  • Pediatric
Check this website regularly for new stories of advancement and discovery.